Last updated on April 2020

Dose Optimization Study of Idelalisib in Follicular Lymphoma

Brief description of study

The primary objective of this study is to establish a safe and effective dosing regimen of idelalisib in participants with relapsed or refractory follicular lymphoma (FL) who have no other therapeutic options.

Clinical Study Identifier: NCT02536300

Find a site near you

Start Over

Calvary Hospital

Woodville South, Australia
  Connect »

Calvary Hospital

North Adelaide, Australia
  Connect »